Division of Cardiothoracic Surgery, Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
Ann Thorac Surg. 2022 Jul;114(1):e17-e19. doi: 10.1016/j.athoracsur.2021.10.004. Epub 2021 Nov 5.
Lung transplantation has been well described for patients with coronavirus disease 2019 (COVID-19) in the acute setting, but less so for the resulting pulmonary sequelae. This report describes a case of lung transplantation for post-COVID-19 pulmonary fibrosis. A 52-year-old woman contracted COVID-19 in July 2020 and mounted a partial recovery, but she went on to have declining function over the ensuing 3 months, with development of fibrocystic lung changes. She underwent bilateral lung transplantation and recovered rapidly, was discharged home on postoperative day 14, and has done well in follow-up. This case report demonstrates that lung transplantation is an acceptable therapy for post-COVID-19 pulmonary fibrosis.
肺移植在 COVID-19 急性发病期的患者中已有很好的描述,但对于由此产生的肺部后遗症则描述较少。本报告描述了一例 COVID-19 后肺纤维化患者的肺移植。一名 52 岁女性于 2020 年 7 月感染 COVID-19,部分康复,但随后在接下来的 3 个月中功能逐渐下降,出现纤维囊性肺部改变。她接受了双侧肺移植,术后恢复迅速,在术后第 14 天出院,随访情况良好。本病例报告表明,肺移植是 COVID-19 后肺纤维化的一种可行治疗方法。